BGC > Produktsuche > Abiraterone | 154229-19-3

Appearance	White or off white crystalline powder
Identification	The retention time of the major peak in the chromatogram of the test preparation corresponds to that in the chromatogram of the reference preparation
Related Substance	Single impurity ≤ 0.5%
Total impurity	≤ 1.0%
Moisture	≤ 0.5%
Residue on ignition	≤ 0.1%
Heavy metal	≤ 10ppm
Assay (dry basis)	Not less than 99.0% (HPLC)

Molecular Formula: C24H31NO
Molecular Weight: 349.51

Description:
Abiraterone blocks the synthesis of androgens by inhibiting CYP17A1. It is used to treat metastatic, castration-resistant prostate cancer.

• Molecular Weight:349.51
• Melting Point:224-226 °C
• Purity:>98%

Molecular Formula:
C24H31NO
Canonical SMILES:
CC12CCC(CC1=CCC3C2CCC4(C3CC=C4C5=CN=CC=C5)C)O
InChI:
InChI=1S/C24H31NO/c1-23-11-9-18(26)14-17(23)5-6-19-21-8-7-20(16-4-3-13-25-15-16)24(21,2)12-10-22(19)23/h3-5,7,13,15,18-19,21-22,26H,6,8-12,14H2,1-2H3/t18-,19-,21-,22-,23-,24+/m0/s1
InChIKey:
GZOSMCIZMLWJML-VJLLXTKPSA-N
Appearance:
White Solid
Application:
the treatment of metastatic, castration-resistant prostate cancer
Synonyms:
(3beta)-17-(3-pyridinyl)-androsta-5,16-dien-3-ol; 17-(3-Pyridyl)androsta-5,16-dien-3beta-ol; CB 7598; CB-7598; CB7598